FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000756066> ?p ?o ?g. }

• W2000756066 endingPage "692" @default.
• W2000756066 startingPage "685" @default.
• W2000756066 abstract "Inhibitors of the angiotensin-converting enzyme (ACE) decrease angiotensin II production and activate an intracellular signaling cascade that affects gene expression in endothelial cells. Because ACE inhibitors have been reported to delay the onset of type 2 diabetes, we determined ACE signaling-modulated gene expression in endothelial cells and adipocytes. Using differential gene expression analysis, several genes were identified that were 3-fold up- or down-regulated by ramiprilat in cells expressing wild-type ACE versus cells expressing a signaling-dead ACE mutant. One up-regulated gene was the cellular retinol-binding protein 1 (CRBP1). In adipocytes, the overexpression of CRBP1 enhanced (4- to 5-fold) the activity of promoters containing response elements for retinol-dependent nuclear receptors [retinoic acid receptor (RAR) and retinoid X receptor (RXR)] or peroxisome proliferator-activated receptors (PPAR). CRBP1 overexpression also enhanced the promoter activity (by 470 ± 40%) and expression/release of the anti-inflammatory and antiatherogenic adipokine adiponectin (cellular adiponectin by 196 ± 24%, soluble adiponectin by 228 ± 74%). Significantly increased adiponectin secretion was also observed after ACE inhibitor treatment of human preadipocytes, an effect prevented by small interfering RNA against CRBP1. Furthermore, in <i>ob</i>/<i>ob</i> mice, ramipril markedly potentiated both the basal (approximately 2-fold) and rosiglitazonestimulated circulating levels of adiponectin. In patients with coronary artery disease or type 2 diabetes, ACE inhibition also significantly increased plasma adiponectin levels (1.6- or 2.1-fold, respectively). In summary, ACE inhibitors affect adipocyte homeostasis via CRBP1 through the activation of RAR/RXR-PPAR signaling and up-regulation of adiponectin. The latter may contribute to the beneficial effects of ACE inhibitors on the development of type 2 diabetes in patients with an activated renin-angiotensin system." @default.
• W2000756066 created "2016-06-24" @default.
• W2000756066 creator A5020241110 @default.
• W2000756066 creator A5029332875 @default.
• W2000756066 creator A5055750914 @default.
• W2000756066 creator A5069711782 @default.
• W2000756066 creator A5077770411 @default.
• W2000756066 creator A5091173895 @default.
• W2000756066 date "2008-12-29" @default.
• W2000756066 modified "2023-10-03" @default.
• W2000756066 title "Angiotensin-Converting Enzyme (ACE) Inhibitors Modulate Cellular Retinol-Binding Protein 1 and Adiponectin Expression in Adipocytes via the ACE-Dependent Signaling Cascade" @default.
• W2000756066 cites W1563173655 @default.
• W2000756066 cites W180946569 @default.
• W2000756066 cites W1965800022 @default.
• W2000756066 cites W1971638152 @default.
• W2000756066 cites W1993800499 @default.
• W2000756066 cites W2002462866 @default.
• W2000756066 cites W2004295653 @default.
• W2000756066 cites W2023128145 @default.
• W2000756066 cites W2023755744 @default.
• W2000756066 cites W2031772023 @default.
• W2000756066 cites W2036696954 @default.
• W2000756066 cites W2042390289 @default.
• W2000756066 cites W2043200338 @default.
• W2000756066 cites W2048748448 @default.
• W2000756066 cites W2063307081 @default.
• W2000756066 cites W2079080809 @default.
• W2000756066 cites W2082304625 @default.
• W2000756066 cites W2098412223 @default.
• W2000756066 cites W2099334382 @default.
• W2000756066 cites W2104030002 @default.
• W2000756066 cites W2104491672 @default.
• W2000756066 cites W2108931588 @default.
• W2000756066 cites W2109511937 @default.
• W2000756066 cites W2113273743 @default.
• W2000756066 cites W2129697991 @default.
• W2000756066 cites W2137989376 @default.
• W2000756066 cites W2138458089 @default.
• W2000756066 cites W2154559194 @default.
• W2000756066 cites W2161392015 @default.
• W2000756066 cites W2164310769 @default.
• W2000756066 cites W2188558428 @default.
• W2000756066 cites W4233100367 @default.
• W2000756066 cites W46238794 @default.
• W2000756066 doi "https://doi.org/10.1124/mol.108.051631" @default.
• W2000756066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19114589" @default.
• W2000756066 hasPublicationYear "2008" @default.
• W2000756066 type Work @default.
• W2000756066 sameAs 2000756066 @default.
• W2000756066 citedByCount "26" @default.
• W2000756066 countsByYear W20007560662012 @default.
• W2000756066 countsByYear W20007560662013 @default.
• W2000756066 countsByYear W20007560662014 @default.
• W2000756066 countsByYear W20007560662015 @default.
• W2000756066 countsByYear W20007560662016 @default.
• W2000756066 countsByYear W20007560662018 @default.
• W2000756066 countsByYear W20007560662019 @default.
• W2000756066 countsByYear W20007560662020 @default.
• W2000756066 countsByYear W20007560662022 @default.
• W2000756066 crossrefType "journal-article" @default.
• W2000756066 hasAuthorship W2000756066A5020241110 @default.
• W2000756066 hasAuthorship W2000756066A5029332875 @default.
• W2000756066 hasAuthorship W2000756066A5055750914 @default.
• W2000756066 hasAuthorship W2000756066A5069711782 @default.
• W2000756066 hasAuthorship W2000756066A5077770411 @default.
• W2000756066 hasAuthorship W2000756066A5091173895 @default.
• W2000756066 hasConcept C126322002 @default.
• W2000756066 hasConcept C134018914 @default.
• W2000756066 hasConcept C170493617 @default.
• W2000756066 hasConcept C171089720 @default.
• W2000756066 hasConcept C187345961 @default.
• W2000756066 hasConcept C2776175234 @default.
• W2000756066 hasConcept C2776782570 @default.
• W2000756066 hasConcept C2777391703 @default.
• W2000756066 hasConcept C2779306644 @default.
• W2000756066 hasConcept C2908929049 @default.
• W2000756066 hasConcept C71924100 @default.
• W2000756066 hasConcept C86803240 @default.
• W2000756066 hasConceptScore W2000756066C126322002 @default.
• W2000756066 hasConceptScore W2000756066C134018914 @default.
• W2000756066 hasConceptScore W2000756066C170493617 @default.
• W2000756066 hasConceptScore W2000756066C171089720 @default.
• W2000756066 hasConceptScore W2000756066C187345961 @default.
• W2000756066 hasConceptScore W2000756066C2776175234 @default.
• W2000756066 hasConceptScore W2000756066C2776782570 @default.
• W2000756066 hasConceptScore W2000756066C2777391703 @default.
• W2000756066 hasConceptScore W2000756066C2779306644 @default.
• W2000756066 hasConceptScore W2000756066C2908929049 @default.
• W2000756066 hasConceptScore W2000756066C71924100 @default.
• W2000756066 hasConceptScore W2000756066C86803240 @default.
• W2000756066 hasIssue "3" @default.
• W2000756066 hasLocation W20007560661 @default.
• W2000756066 hasLocation W20007560662 @default.
• W2000756066 hasOpenAccess W2000756066 @default.
• W2000756066 hasPrimaryLocation W20007560661 @default.
• W2000756066 hasRelatedWork W2013033377 @default.
• W2000756066 hasRelatedWork W2020571025 @default.
• W2000756066 hasRelatedWork W2022430938 @default.

• next